Breast cancer is a heterogeneous disease, encompassing a large number of entities
showing different morphological features and having clinical behaviors. It has became …

Breast cancer is a heterogeneous disease with different morphologies, molecular profiles,
clinical behaviour and response to therapy. The triple negative is a particular type of breast …

Aims and background Triple-negative breast cancer, defined by a lack of expression of
estrogen, progesterone and HER-2 receptors, accounts for 15% of all types of breast cancer …

The recent advances in pathological and molecular knowledge have changed the
landscape of breast cancer, with triple-negative breast cancer emerging as a pathological …

Triple negative breast cancer is a heterogeneous group of tumors, lacking the expression of
estrogen, progesterone and HER-2 receptors. As frequency, it accounts about 15–20% of all …

Triple-negative breast cancers (TNBCs) are more likely to occur in younger patients and
have a poor prognosis. They are highly heterogeneous tumors consisting of different …

Triple negative breast cancer is an aggressive form of breast cancer with limited treatment
options and is without proven targeted therapy. Understanding the molecular basis of triple …

Introduction: Triple-negative breast cancer (TNBC) makes up about 10–20% of all breast
cancers and the lack of hormone receptors and human epidermal growth factor receptor …

Triple-negative breast cancer has recently been recognized as an important subgroup of
breast cancer with a distinct outcome and therapeutic approach when compared with other …

As we prepare for an era of targeted and individualized medicine, limited understanding of
triple negative breast cancer biology presents a challenge in developing novel therapies …